AcademyHealth: Should we pay more for vaccines?

It’s fashionable to complain that drug prices are too high. But they’re relatively low for some of them most effective drugs we have — vaccines. That may be the cause of shortages, as my latest AcademyHealth post explains.

@afrakt

 

Share on twitter
Share on facebook
Share on linkedin
Share on reddit
Share on email

Hidden information below

Austin Frakt

Austin Frakt, PhD, is co-Editor-in-Chief of The Incidental Economist and tweets at @afrakt. His day job is Director of the Partnered Evidence-based Policy Resource Center at the Boston VA Healthcare System, U.S. Department of Veterans Affairs. He is also a Professor with the Department of Health Law, Policy and Management at the Boston University’s School of Public Health, a Principal Research Scientist with the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health, and Editor-in-Chief of the journal Health Services Research.

The Incidental Economist

the health services research blog

Editors In Chief
Managing Editor

Work posted here under copyright © of the authors • Details on the Site Policies page

Subscribe

* indicates required
Email Format